Drug
E7090
E7090: highest development phase Phase 1, developed by Eisai. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| E7090 NCT02275910 | Phase 1 | Tumors |
| E7090 NCT04572295 | Phase 1 | Breast Neoplasms |
Latest
No recent events.
Follow E7090 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.